Dr. Satyabrata Meher is an accomplished biomedical researcher with extensive expertise in sickle cell disease, hemoglobinopathies, molecular hematology, genetic polymorphisms, and clinical laboratory research. He is currently serving as Research Scientist-I at the Multidisciplinary Research Unit (MRU) (under ICMR-DHR), Veer Surendra Sai Institute of Medical Science and Research (VIMSAR), Burla, Sambalpur, Odisha. His professional association with the Odisha Sickle Cell Project under the National Health Mission (NHM) spans more than a decade, progressing through the roles of Field Worker, Programme Associate, and Research Assistant.

His sustained involvement in sickle cell research has contributed to the understanding of the clinical, hematological, biochemical, and molecular characteristics of sickle cell disease in Odisha and Eastern India.

Research Expertise & Contributions

Dr. Meher's research career has been strongly focused on improving scientific understanding of sickle cell disease and related hemoglobinopathies. His work encompasses:

• Molecular characterization of sickle cell and β-thalassemia disorders.
• Investigation of genetic modifiers and gene polymorphisms associated with disease severity.
• Research on vaso-occlusive crisis (VOC), acute chest syndrome, hemolysis, and oxidative stress.
• Studies involving HMOX-1, eNOS, haptoglobin, MTHFR and XmnI polymorphisms.
• Investigation of fetal hemoglobin (HbF), alpha-thalassemia and β-globin haplotypes.
• Research on the clinical response and effectiveness of hydroxyurea therapy.
• Identification and characterization of rare hemoglobin variants and compound heterozygous conditions.
• Research on hematological and biochemical biomarkers relevant to sickle cell disease.

He has also prepared and submitted 12 research proposals to the Institutional Ethical Committee at VIMSAR, Burla, covering areas such as genetic modifiers, hydroxyurea therapy, hemoglobinopathies, iron metabolism, reticulocyte and F-cell analysis, and molecular mechanisms of vaso-occlusive crisis.

Publication & Scholarly Contribution

Dr. Meher has published more than 40 research articles in internationally reputed scientific journals. His research has therefore contributed to both fundamental understanding and clinically relevant investigation of sickle cell disorders, particularly within the population of Odisha and Eastern India. His research focuses on molecular genetics, disease modifiers, biomarkers, hydroxyurea therapy, and the clinical and laboratory aspects of sickle cell disorders. Beyond his research, Dr. Meher has developed multiple research proposals, served as a reviewer for reputed scientific journals, and presented his work at numerous national and international conferences. During the COVID-19 pandemic, he also contributed to establishing the RT-PCR diagnostic laboratory at VIMSAR, Burla.

Research Projects & Scientific Leadership

A significant aspect of Dr. Meher's profile is his long-term involvement in the Odisha Sickle Cell Project, where he has contributed to patient-oriented research, laboratory investigations, epidemiological studies, molecular characterization, and therapeutic research.

He has been involved in developing research proposals addressing important areas including:

• β-globin gene haplotypes and genetic modifiers.
• Hydroxyurea response in sickle cell disease.
• Abnormal hemoglobins in Odisha.
• Epidemiological and clinical profiles of sickle cell disease.
• Genetic determinants of disease severity.
• Haptoglobin and HMOX-1 in VOC and hemolysis.
• Iron status in sickle cell disease.
• Molecular and pathophysiological mechanisms of vaso-occlusive crisis.

COVID-19 Laboratory Contribution

During the COVID-19 pandemic, Dr. Meher was a member of the team responsible for initiating and standardizing the RT-PCR-based COVID-19 laboratory testing facility at VIMSAR, Burla. This contribution demonstrates his ability to apply laboratory expertise to an urgent public-health requirement.

Awards & Recognition

Dr. Meher has received several recognitions for his scientific and research presentations, including:

• Young Scientist Award – 2015, National Conference on Frontiers in Life Sciences, Sambalpur University.
• Best Oral Presentation Award – 2018 for research on hyperhomocysteinemia and MTHFR C677T polymorphism in sickle cell anemia.
• Best Poster Presentation Award – 2017 (Third Prize) for research on eNOS and HMOX-1 gene polymorphisms and clinical severity of sickle cell anemia.
• Award of Appreciation and Gratitude – 2015 for poster presentation on sickle cell disease in Western Odisha.

These recognitions reflect the scientific quality and relevance of his research work.

Conference Participation & Scientific Communication

He has actively disseminated his research through oral presentations, poster presentations and e-posters at national and international scientific meetings. His presentations have addressed genetic determinants of sickle cell disease, rare hemoglobin variants, hydroxyurea therapy, vaso-occlusive crisis, haptoglobin, fetal hemoglobin and hemoglobinopathies.

He has also presented research at major scientific forums, including the Global Congress on Sickle Cell Disease, International Symposium on Technological Innovations in Laboratory Hematology, Indian Genetic Congress, and meetings of the Indian Society of Haematology and Blood Transfusion.

Professional & Academic Service

Dr. Meher is a Life Member of the Indian Society of Haematology & Blood Transfusion (ISHBT). He has also contributed to the peer-review process of reputed journals, including Turkish Journal of Hematology, Scandinavian Journal of Clinical & Laboratory Investigation, Frontiers in Medicine and Hematology, and Transfusion and Cell Therapy.

His reviewer responsibilities demonstrate recognition of his subject expertise within the hematology and biomedical research community.

Overall Research Impact

With a research career extending over 15 years, Dr. Satyabrata Meher has established a strong research profile in sickle cell disease and molecular hematology. His work combines laboratory research, molecular genetics, clinical investigation, epidemiology and translational aspects of hemoglobinopathies. His sustained contribution to sickle cell research in Odisha, extensive publication record, scientific presentations, research proposal development, peer-review activities and multiple research awards collectively demonstrate a meaningful contribution to biomedical science.

Eligibility for Distinguished Researcher Award

Dr. Satyabrata Meher is highly eligible for the Distinguished Researcher Award in Scientific Laurels based on his sustained and specialized research contributions in sickle cell disease and hemoglobinopathies. His profile is distinguished by long-term research experience, substantial scholarly publications, innovative molecular and clinical investigations, multiple scientific awards, research proposal development, international and national conference participation, journal reviewing responsibilities, and significant contributions to sickle cell patients of Odisha.

His research addressing the genetic, molecular, biochemical and clinical determinants of sickle cell disease, together with his contribution to COVID-19 diagnostic laboratory establishment, demonstrates both scientific excellence and societal relevance. These accomplishments strongly support his nomination for recognition as a Distinguished Researcher in the field of biomedical and hematological research.